Fundraising FoxVentureSouth — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
mPATH Health develops an SMS-based behavioral science platform that guides patients through cancer screening decisions and increases completion rates across lung, breast, and colorectal screening programs.
Digital HealthHealthtechMedical DevicesSaaSWake Forest, US
David Miller(Founder & Physician)inAjay Dharod(Co-founder & Physician)in
Co-investorsOncology VenturesAtlanta Technology AngelsFirst Launch Capital
Redbud Labs develops microfluidics-based technology for sample preparation products.
BiotechDeep TechHardwareHealthtechChapel Hill, US
Richard Superfine(Director)inRichard C. Spero(Executive Officer, Director)
BoardKenneth P West(Director)
Co-investorsNC IDEA
Yuva Biosciences develops and licenses Y100, a cosmetic active ingredient that enhances mitochondrial health to reduce visible signs of aging for use in skincare and haircare products.
AI & Machine LearningBiotechConsumerHealthtechLongevityBirmingham, US
Greg Schmergel(Executive Officer, Director)
BoardFred Ehrsam(Director)Daniel Browne(Director)
Co-investorsInnovation DepotTBD AngelsWestern Technology Investment
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CADchat
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.